Question 1

Is ibogaine therapy legal in Mexico?

Accepted Answer

Yes, ibogaine treatment is permitted in licensed clinics across Mexico, provided the facility follows health regulations. Ibogaine is a Schedule I substance in the US, but it is legal and unregulated in Mexico, which is why clinics operate there. It is also available in New Zealand (by prescription), some Brazilian states, the Netherlands, and Canada (Special Access Program).

Question 2

What is the success rate for addiction recovery with ibogaine?

Accepted Answer

Clinical studies report a 60–70% reduction in relapse rates when ibogaine is combined with aftercare programs. The Stanford MISTIC study (2024, Nature Medicine) documented an 88% average reduction in PTSD symptoms and an 87% reduction in depression symptoms among special operations veterans after a single ibogaine treatment.

Question 3

Is ibogaine safe?

Accepted Answer

Ibogaine carries real risks, particularly cardiac risks such as QT interval prolongation. However, when administered in a properly equipped medical facility with comprehensive pre-screening (EKG, blood work, drug panel) and continuous cardiac monitoring, the risk profile is significantly reduced. Approximately 33 ibogaine-related deaths are documented in the scientific literature, the vast majority in unmonitored settings without medical oversight.

Question 4

How much does ibogaine treatment cost in Mexico?

Accepted Answer

Treatment in Mexico typically ranges from $5,000 to $20,000+, with the average falling between $8,000 and $12,500. This usually includes medical screening, ibogaine HCL treatment with continuous cardiac monitoring, 24/7 medical supervision, private accommodation for 5–7 days, meals, integration therapy sessions, and airport transfers.

Question 5

What is ibogaine?

Accepted Answer

Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the African shrub Tabernanthe iboga. It interacts with multiple brain systems simultaneously — serotonin, dopamine, opioid receptors, and NMDA glutamate receptors — and upregulates GDNF (glial cell line-derived neurotrophic factor), which promotes neuronal survival and repair.

Question 6

How does ibogaine work for addiction?

Accepted Answer

Ibogaine targets addiction at the neurological root in a single medically supervised treatment. Its active metabolite noribogaine continues to reduce cravings for weeks to months after treatment. Unlike daily medications such as Suboxone or methadone, ibogaine addresses multiple neurotransmitter systems simultaneously, providing rapid withdrawal relief and sustained craving reduction.

Question 7

What does the Stanford ibogaine study show?

Accepted Answer

The MISTIC study (Magnesium–Ibogaine: the Stanford Traumatic Injury to the CNS study), published in Nature Medicine in 2024, enrolled 30 Special Operations veterans with traumatic brain injury. Results showed an 88% reduction in PTSD symptoms, 87% reduction in depression, 81% reduction in anxiety, and disability ratings dropping from 30.2 to 5.1 at one month post-treatment.

Question 8

Who should NOT take ibogaine?

Accepted Answer

People with certain heart conditions (long QT syndrome, arrhythmias, heart disease), liver disease, pregnancy, untreated psychotic disorders, or those on certain medications (SSRIs must be tapered, methadone requires specialist management). A thorough medical screening including EKG and blood work is essential before treatment.

Question 9

How long does ibogaine treatment take?

Accepted Answer

The ibogaine experience itself lasts 12–24 hours. Most clinic programs are 5–14 days total, including pre-treatment medical assessment, the treatment itself, and post-treatment recovery and integration therapy.

Question 10

Does ibogaine work for PTSD in veterans?

Accepted Answer

Yes. Stanford research documented an 88% average reduction in PTSD symptoms among special operations veterans after a single ibogaine treatment. The mechanism involves neuroplasticity, memory reprocessing, theta rhythm restoration, and GDNF-driven neural repair. An estimated 22 US veterans die by suicide every day, and ibogaine represents a fundamentally different approach for treatment-resistant cases.

Ibogaine in the News

Trump Signs Ibogaine Executive Order: Accelerating Medical Treatments for Serious Mental Illness

Texas Commits $50 Million to Ibogaine Research Initiative

VA Announces Psychedelic Therapy Trials at 9 Facilities

Stanford MISTIC Study Published in Nature Medicine

Arizona Allocates $5 Million for Ibogaine Phase I Trials

'In Waves and War' Documentary Released on Netflix

The Ibogaine Briefing